Featured Archives - Inceptua Group

Is there a role for Ethics Committees in Pre-approval Access?

Stuart Bell, Vice President, Consulting, Inceptua Medicines Access In discussions with our clients over recent months the topic of ethics committee involvement in pre-approval access programs (expanded access, compassionate use,…

Stuart BellJanuary 14, 2021

Featured Inceptua Pharma Press release

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe

Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe December 28 2020, Elevar Therapeutics, Inc, a fully integrated biopharmaceutical company built…

Inceptua GroupDecember 28, 2020

Featured Press release

Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease

LUXEMBOURG, Dec. 3, 2020 Inceptua announces that the company has entered into a partnership with Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company focused on discovering, developing and delivering treatments…

Inceptua GroupDecember 3, 2020

Clinical Trial Services Featured

Webinar: Strategic Comparator Sourcing in China

Optimizing the Clinical Supply Chain China is now the second-largest pharmaceutical market in the world, and with a more harmonized and efficient clinical trial approval process, it is seeing a…

Inceptua GroupNovember 30, 2020

Featured Medicines Access

Pre-approval Access

Regulatory Update 2020 Stuart Bell, Vice President, Consulting, Inceptua Medicines Access The regulations governing pre-approval access (early access, expanded access, compassionate use, named patient supply etc.) are constantly being updated…

Stuart BellNovember 6, 2020

Clinical Trial Services Featured

Safely and Reliably Supplying your Comparator Needs during COVID19

Maintaining Safe and Reliable Supply of Comparators during COVID19 As an agile, well-distributed and robust global supplier of Comparators for the biopharmaceutical industry, Inceptua is uniquely positioned to safely and…

Inceptua GroupNovember 2, 2020

Featured Inceptua Pharma Update

Helping get orphan drugs to patients quicker

Across Europe there is disparity in the average time for new drugs to be approved and accessible to patients. There are a number of factors delaying these processes. Stuart Bell,…

Stuart BellOctober 7, 2020

Featured Press release

Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion

LUXEMBOURG – 25 September, 2020 – Inceptua Group – pharmaceutical company and service partner announces that the European Commission (EC) has approved the transfer of the marketing authorisation for Jetrea®…

Inceptua GroupSeptember 25, 2020

Featured Press release

Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema

LUXEMBOURG – June 26, 2020 –Inceptua Group – pharmaceutical company and service partner spanning throughout the product lifecycle – from clinical trial comparator sourcing, packaging, labelling, and distribution solutions, through…

Inceptua GroupJune 26, 2020

Featured Press release

Global License Agreement a Building Block in Strategic Growth Plans

LUXEMBOURG – 23 March, 2020 – Inceptua – pharmaceutical company and service partner - and biopharmaceutical company Oxurion have announced a global license agreement for the commercialization of JETREA®, a…

Inceptua GroupMarch 23, 2020

1 2 Next